Fennec director granted 20,000 stock options
FENNEC PHARMACEUTICALS INC. director Jodi A. Cook received a compensation-related grant of stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
FENNEC PHARMACEUTICALS INC. director Jodi A. Cook received a compensation-related grant of stock options. On June 10, 2026, Cook was granted a non-qualified stock option to purchase 20,000 common shares at an exercise price of $8.70 per share under the company’s Equity Incentive Plan. The option is 100% vested on the grant date and expires on June 10, 2036. Following this award, Cook holds stock options covering a total of 160,000 shares.
Insider Trade Summary
Grant/Award: 20,000 shares
Grant/Award
1 txn
Insider
Cook Jodi A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 20,000 | $8.70 | $174K |
Holdings After Transaction:
Stock Options — 160,000 contracts (Direct)
Footnotes (2)
- F1. On June 10, 2026, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
- F2. The option is 100% vested on date of grant.
Key Figures
Option grant size: 20,000 options
Exercise price: $8.70 per share
Expiration date: June 10, 2036
+2 more
5 metrics
Option grant size
20,000 options
Non-qualified stock options granted June 10, 2026
Exercise price
$8.70 per share
Strike price for 20,000 options
Expiration date
June 10, 2036
Option term end for this grant
Underlying shares
20,000 common shares
Shares subject to this option grant
Total options after grant
160,000 options
Total stock options held following transaction
Key Terms
non-qualified stock option, Equity Incentive Plan, exercise price, vested, +1 more
5 terms
non-qualified stock option financial
"Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Equity Incentive Plan financial
"pursuant to the issuer's Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
exercise price financial
"conversion_or_exercise_price": "8.7000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vested financial
"The option is 100% vested on date of grant."
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did FENNEC PHARMACEUTICALS (FENC) director Jodi Cook report in this Form 4?
Director Jodi A. Cook reported receiving a grant of non-qualified stock options for 20,000 FENNEC PHARMACEUTICALS common shares. The award is a compensation-related acquisition under the company’s Equity Incentive Plan, not an open-market stock purchase or sale.
How large is Jodi Cook’s new stock option grant at FENNEC PHARMACEUTICALS (FENC)?
The grant covers options to purchase 20,000 FENNEC PHARMACEUTICALS common shares. Each option has an exercise price of $8.70 per share, as disclosed in the Form 4, and represents an additional equity incentive for the director.
What is the exercise price and expiration date of Jodi Cook’s FENC stock options?
The stock options have an exercise price of $8.70 per FENNEC PHARMACEUTICALS common share and expire on June 10, 2036. These terms define the cost to acquire shares and the timeframe during which the options can be exercised.
When do Jodi Cook’s FENNEC PHARMACEUTICALS (FENC) options vest?
The options are 100% vested on the grant date of June 10, 2026. Immediate vesting means Cook has the right to exercise all 20,000 options, subject to the exercise price and expiration date set in the award.
How many FENC stock options does Jodi Cook hold after this transaction?
After this grant, Jodi A. Cook holds stock options covering a total of 160,000 FENNEC PHARMACEUTICALS common shares. This total includes the newly granted 20,000 options reported in the Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
